Leading Biology provides comprehensive in-house services spanning the entire workflow – from upstream peptide design/synthesis and eukaryotic recombinant protein expression to downstream antibody purification and functional validation. Leveraging our proprietary antigen prediction software, we achieve a 95% success rate in designing immunogenic peptide antigens. Combined with advanced peptide synthesis technologies, we can rapidly produce peptide antigens with purity exceeding 85%.
